Pluristem victorious after EPO opposition proceedings

08-10-2014

A patent belonging to Pluristem Therapeutics covering a treatment for ischemia has been upheld by the European Patent Office (EPO) following opposition proceedings, the company has announced.


ischemia, Pluristem, EPO, opposition proceedings

LSIPR